M&A Deal Summary

Lupin Acquires Laboratorios Grin S.A. de C.V.

On September 30, 2014, Lupin acquired life science company Laboratorios Grin S.A. de C.V.

Acquisition Highlights
  • This is Lupin’s 3rd transaction in the Life Science sector.
  • This is Lupin’s 1st transaction in Mexico.

M&A Deal Summary
Date 2014-09-30
Target Laboratorios Grin S.A. de C.V.
Sector Life Science
Buyer(s) Lupin
Deal Type Add-on Acquisition

Target

Laboratorios Grin S.A. de C.V.

Mexico City, Mexico
Laboratorios Grin S.A. de C.V. is a specialty pharmaceutical company engaged in the development, manufacturing & commercialization of branded Ophthalmic products.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Lupin

Mumbai, India
Category Company
Founded 1968
Sector Life Science
Employees19,210
Revenue 196.6B INR (2024)
DESCRIPTION

Lupin is an innovation-led transnational pharmaceutical company producing and developing a wide range of branded & generic formulations, APIs and biotechnology products. Lupin was founded in 1968 and is based in Mumbai, India.

DEAL STATS #
Overall 3 of 9
Sector (Life Science) 3 of 8
Type (Add-on Acquisition) 2 of 6
Country (Mexico) 1 of 1
Year (2014) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-01-30 Nanomi B.V.

Oldenzaal, Netherlands

Nanomi B.V. is a drug delivery company that develops pharmaceutical products based on nano- and microparticles. Nanomi targets business-to-business partnerships with pharma and biotech companies.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-07-02 Biocom ZAO

Russia

Biocom ZAO is a pharmaceutical company.

Buy -
Mergr

Product

Company

Legal